(Q43873472)

27 November 2017

title

Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study (English)

1 reference

27 November 2017

1 reference

W Eiermann

1

1 reference

27 November 2017

S Paepke

2

1 reference

27 November 2017

J Appfelstaedt

3

1 reference

27 November 2017

A Llombart-Cussac

4

1 reference

27 November 2017

J Eremin

5

1 reference

27 November 2017

J Vinholes

6

1 reference

27 November 2017

L Mauriac

7

1 reference

27 November 2017

M Ellis

8

1 reference

27 November 2017

M Lassus

9

1 reference

27 November 2017

H A Chaudri-Ross

10

1 reference

27 November 2017

M Dugan

11

1 reference

27 November 2017

M Borgs

12

1 reference

27 November 2017

Letrozole Neo-Adjuvant Breast Cancer Study Group

13

1 reference

27 November 2017

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

11

1 reference

27 November 2017

page(s)

1527-1532

1 reference

Should surgery remain the initial treatment of “operable” breast cancer?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Primary (neoadjuvant) chemotherapy and radiotherapy compared with primary radiotherapy alone in stage IIb-IIIa breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Long-term follow-up of elderly patients randomized to primary tamoxifen or wedge mastectomy as initial therapy for operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Letrozole as primary medical therapy for locally advanced and large operable breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

From adjuvant to neo-adjuvant chemotherapy in high-risk breast cancer: the experience of the Milan Cancer Institute. Steiner Award Lecture 1992.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: preliminary results of a randomised trial: S6

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Neoadjuvant chemotherapy in 126 operable breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013128213451

7 January 2021

Identifiers

DOI

10.1023/A:1013128213451

1 reference

27 November 2017

1 reference